Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
Clinical trial NCT02012959 · TERMINATED
Trial details
- NCT number
- NCT02012959
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-22
- Primary completion
- 2017-07-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.